Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Sakamoto

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 29, 2023
[Hypokalemia and potassium replacement therapy in allogeneic hematopoietic stem cell transplantation]Ichiro Kawashima, Hideto Hyuga, Ayato Nakadate, et al.
International Journal of Hematology|August 31, 2019
CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphomaYuma Sakamoto, Keiichiro Fujii, Shunji Murase, et al.
International Journal of Hematology|September 25, 2023
Pre-exposure prophylaxis with tixagevimab/cilgavimab for coronavirus disease 2019 (COVID-19) during the Omicron BA.5 wave at a single institution in JapanIchiro Kawashima, Hideto Hyuga, Ayato Nakadate, et al.
British Journal of Haematology|November 18, 2020
Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
Cancer Science|November 5, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
International Journal of Hematology|May 10, 2022
Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary diseaseMegumi Koshiishi, Ichiro Kawashima, Hideto Hyuga, et al.
British Journal of Haematology|August 18, 2021
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Hematological Oncology|August 31, 2022
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatmentYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 29, 2023
[Hypokalemia and potassium replacement therapy in allogeneic hematopoietic stem cell transplantation]Ichiro Kawashima, Hideto Hyuga, Ayato Nakadate, et al.
International Journal of Hematology|August 31, 2019
CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphomaYuma Sakamoto, Keiichiro Fujii, Shunji Murase, et al.
International Journal of Hematology|September 25, 2023
Pre-exposure prophylaxis with tixagevimab/cilgavimab for coronavirus disease 2019 (COVID-19) during the Omicron BA.5 wave at a single institution in JapanIchiro Kawashima, Hideto Hyuga, Ayato Nakadate, et al.
British Journal of Haematology|November 18, 2020
Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
Cancer Science|November 5, 2021
Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
International Journal of Hematology|May 10, 2022
Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary diseaseMegumi Koshiishi, Ichiro Kawashima, Hideto Hyuga, et al.
British Journal of Haematology|August 18, 2021
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Hematological Oncology|August 31, 2022
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatmentYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Pageof 4